Healthcare DIVE May 22, 2024
Drugmakers are allowed to impose conditions on which pharmacies they dispense discounted drugs to in the 340B program, according to an appellate court.
Dive Brief:
- Drugmakers are allowed to limit and impose conditions on pharmacies they send discounted drugs to under the 340B program, an appeals court ruled Tuesday.
- The ruling is a win for drug manufacturers, who were previously threatened with fines from the federal government for violating guidance regarding which pharmacies they would send discounted drugs to.
- The Court of Appeals upholds a prior District Court ruling, which sided with drugmakers Novartis Pharmaceuticals and United Therapeutics after they sued the HHS in 2021. It’s the latest ruling regarding the controversial 340B drug program — a separate appellate...
Today's Sponsors
Today's Sponsor